论文部分内容阅读
使用他莫昔芬不宜超过５年两项新的研究表明，用抗雌激素药物他莫昔芬（ｔａｍｏｘｉｆｅｎ）治疗妇女乳腺瘤超过５年并无益处，甚至是有害的。美国国立癌症研究所决定停止一个代号为Ｂ－１４的他莫昔芬长期临床试验，该项试验涉及１１６６例结节阴性、雌激素受体阳性的乳...
Use of tamoxifen for no more than 5 years Two new studies have shown that treating women with breast cancer with the antiestrogen tamoxifen for more than 5 years is not beneficial or even detrimental. The National Cancer Institute decided to discontinue a long-term clinical trial of tamoxifen, code-named B-14, involving 1166 nodular-negative and estrogen receptor-positive milk ...